Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
1996-4-1
pubmed:abstractText
Xeroderma pigmentosum (XP) is an autosomal recessive genetic disorder characterized by an increased frequency of skin cancer following minimal sunlight exposure. Cells isolated from XP patients are also hypersensitive to UV rays and UV-like chemicals. This sensitivity is directly related to a defect in the early steps of nucleotide excision repair (NER) of damaged DNA. No efficient treatment is available for this disease and skin cancer prevention can only be achieved by strict avoidance of sunlight exposure. Thus, we are developing a model for gene therapy in XP, particularly for patients belonging to group D. We report here the construction of a retroviral vector (LXPDSN) containing the XPD (ERCC2) cDNA, which fully complements the DNA repair deficiency of primary skin fibroblasts. Efficient integration, mRNA synthesis, and protein expression of the XPD gene were obtained in all LXPDSN-transduced XP-D fibroblasts tested. Full correction of the DNA repair defect was observed with all DNA repair assays used, such as an increased survival after UV-radiation of the transduced cells, a normal level of DNA repair synthesis (UDS), and the reactivation of a UV-irradiated reporter vector. This retroviral vector will be used to modify keratinocytes genetically to produce repair proficient reconstituted skin for engraftment to XP patients.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1043-0342
pubmed:author
pubmed:issnType
Print
pubmed:volume
6
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1307-15
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:8590735-Cell Survival, pubmed-meshheading:8590735-Cells, Cultured, pubmed-meshheading:8590735-Cloning, Molecular, pubmed-meshheading:8590735-DNA Helicases, pubmed-meshheading:8590735-DNA Repair, pubmed-meshheading:8590735-DNA-Binding Proteins, pubmed-meshheading:8590735-Fibroblasts, pubmed-meshheading:8590735-Gene Therapy, pubmed-meshheading:8590735-Gene Transfer Techniques, pubmed-meshheading:8590735-Genetic Complementation Test, pubmed-meshheading:8590735-Genetic Vectors, pubmed-meshheading:8590735-Humans, pubmed-meshheading:8590735-Moloney murine leukemia virus, pubmed-meshheading:8590735-Phenotype, pubmed-meshheading:8590735-Proteins, pubmed-meshheading:8590735-Skin, pubmed-meshheading:8590735-Transcription Factors, pubmed-meshheading:8590735-Ultraviolet Rays, pubmed-meshheading:8590735-Xeroderma Pigmentosum, pubmed-meshheading:8590735-Xeroderma Pigmentosum Group D Protein
pubmed:year
1995
pubmed:articleTitle
Functional retroviral vector for gene therapy of xeroderma pigmentosum group D patients.
pubmed:affiliation
Laboratory of Molecular Genetics, Institut de Recherches sur le Cancer, CNRS, Villejuif, France.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't